The biologics market has emerged as a cornerstone in the healthcare industry, addressing some of the most challenging medical conditions with innovative therapies. With a valuation of USD 381.9 billion in 2023, the market’s trajectory is set for significant expansion, projected to reach USD 727.3 billion by 2032, growing at a compound annual